China Refurbished Medical Devices Market Overview
As per MRFR analysis, the China Refurbished Medical Devices Market Size was estimated at 663.0 (USD Million) in 2023.The China Refurbished Medical Devices Market is expected to grow from 739.8(USD Million) in 2024 to 1,882.4 (USD Million) by 2035. The China Refurbished Medical Devices Market CAGR (growth rate) is expected to be around 8.861% during the forecast period (2025-2035).
Key China Refurbished Medical Devices Market Trends Highlighted
Due to rising healthcare costs, there is a discernible trend in the China Refurbished Medical Devices Market toward a greater need for affordable healthcare solutions.
The Chinese government has advocated for regulations that promote the use of reconditioned medical devices, enabling hospitals and clinics to save money without compromising quality, in recognition of the need for reasonably priced medical services.
Refurbishing equipment is viewed as a feasible solution to satisfy the expanding needs of medical institutions in both urban and rural locations, as healthcare expenses become a concern for both the public and private sectors. With the increasing prevalence of technology breakthroughs in refurbishing processes, the market is booming.
Businesses can take advantage of the growing healthcare infrastructure upgrades in second and third-tier cities by looking into joint ventures with manufacturers or healthcare providers for reconditioned devices.
Additionally, there is potential to serve specialty markets like surgical tools, anesthesia equipment, and imaging devices, which might not have many refurbished models accessible.
As healthcare professionals and organizations in China become more aware of the advantages, they are increasingly embracing pre-owned medical gadgets. Refurbished devices show a lower carbon footprint than their new equivalents, indicating a shift toward sustainability.
This pattern is consistent with China's healthcare system's larger focus on environmental responsibility. Furthermore, both customers and providers now have more faith in the industry because of China's improved quality assurance norms and laws for reconditioned medical products.
Because it fits with the nation's healthcare objectives and economic plans, all of these considerations point to a growing market for reconditioned medical equipment.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
China Refurbished Medical Devices Market Drivers
Increasing Demand for Cost-Effective Medical Solutions
In China, the rising healthcare expenses have led to a notable shift towards cost-effective medical solutions, which include the adoption of refurbished medical devices.
With the Chinese government implementing policies aimed at reducing healthcare costs and increasing access to medical treatments, the refurbished medical devices market is set to flourish. In light of recent developments by the National Health Commission of China, healthcare expenditure as a percentage of GDP reached around 7.1%, illustrating a significant investment trend.
This transition reflects a broader aim to ensure effective healthcare provision across various demographics, thereby intensifying the demand within the China Refurbished Medical Devices Market.
Moreover, the use of refurbished devices has been reported to save approximately 40-60% of hospitals compared to acquiring new equipment, leading to accelerated adoption in lower-tier hospitals, where budget constraints are more pressing.
Government Support and Policy Initiatives
The Chinese government is fostering an environment favorable for the growth of the refurbished medical devices market through various supportive policies.
The introduction of guidelines by the Ministry of Industry and Information Technology to promote the circular economy aligns seamlessly with the objectives of refurbishing medical equipment. These governmental initiatives encourage the recycling and reuse of medical devices, supporting sustainability in the healthcare sector.
For instance, the Ministry's incentivization of refurbished equipment has shown an upward trend, resulting in a reported 25% increase in refurbished device approvals since 2020. This focus on sustainable practices within the China Refurbished Medical Devices Market signifies a crucial driver for market growth.
Technological Advancements in Refurbishment Processes
Advancements in technology have significantly enhanced the refurbishment processes of medical devices, making them more reliable and appealing for healthcare providers in China. Companies specializing in refurbishing have adopted sophisticated techniques and quality assurance protocols, which have improved the performance and durability of refurbished devices.
Reports indicate that the implementation of advanced refurbishing technology has increased the lifespan of many medical devices by up to 30%. These technological improvements not only boost the credibility of refurbished products within the China Refurbished Medical Devices Market but also attract end-users by ensuring high safety and performance levels, fostering a broader market acceptance.
China Refurbished Medical Devices Market Segment Insights
Refurbished Medical Devices Market Diagnostic Devices Insights
The Diagnostic Devices segment within the China Refurbished Medical Devices Market plays a crucial role in enhancing healthcare outcomes through advanced imaging and monitoring technologies.
It comprises diverse product categories such as X-Ray Machines, CT Scanners, Ultrasound Systems, MRI Machines, ECG Systems, and Patient Monitors, each having its significance in the medical diagnostics landscape.
X-Ray Machines serve as one of the foundational imaging tools, supporting a variety of diagnostic needs, while CT Scanners provide detailed cross-sectional images, proving essential in oncology and trauma evaluations.
Ultrasound Systems are increasingly used for their non-invasive capabilities and are essential in prenatal care, while MRI Machines are pivotal for neurological assessments due to their detailed imaging of soft tissues. ECG Systems are vital in cardiology for monitoring heart conditions and diagnosing potential illnesses.
Patient Monitors play a key role in critical care, offering real-time insights into patients’ vital signs, thus facilitating timely interventions. The growing emphasis on cost-effective healthcare solutions, combined with technological advancements, has driven the preference for refurbished medical devices, making this segment increasingly significant.
In China, where healthcare accessibility and affordability remain priorities, the Diagnostic Devices segment contributes substantially to addressing the demands of both urban and rural clinics.
Moreover, local government policies aimed at improving healthcare infrastructure and promoting the use of refurbished devices further solidify the segment's growth potential within the China Refurbished Medical Devices Market.
The expansion of medical facilities, coupled with a large aging population requiring advanced diagnostic services, creates ample opportunities for growth in this segment, supporting a trend toward the reliable, quality, and economically feasible healthcare solutions that refurbished diagnostic devices represent.
Moreover, the rising demand for early disease detection and the increased focus on preventive healthcare measures are linked closely to the adoption of technologies within this segment, making it a dynamic area of growth.
Overall, the importance and versatility of the Diagnostic Devices segment contribute meaningfully to the broader scope of the China Refurbished Medical Devices Market, enabling healthcare providers to enhance diagnostic precision and improve patient outcomes effectively.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Refurbished Medical Devices Market Therapeutic Devices Insights
The Therapeutic Devices segment within the China Refurbished Medical Devices Market is integral to advancing healthcare and addressing the unique needs of patients across various therapeutic procedures. This segment includes a variety of critical devices essential for life support and monitoring, such as Heart-Lung Machines, which play a vital role during surgeries requiring prolonged cardiac support.
Coagulation Analyzers are increasingly significant in managing bleeding disorders and ensuring safe surgical outcomes, while Infant Incubators and Warmers are crucial for supporting the health of premature and ill newborns, thereby improving survival rates in neonatal care.
Defibrillators are essential for cardiac emergencies, and their refurbished models are gaining prevalence due to cost-effectiveness and sustainability efforts in healthcare. Infusion Pumps, responsible for delivering essential medications and nutrients accurately, also dominate the landscape as the demand for precise medication management grows.
Overall, the Therapeutic Devices segment is characterized by a strong emphasis on enhancing patient outcomes and reducing healthcare costs within the increasingly digital and rehabilitative landscape of China's medical environment.
China Refurbished Medical Devices Market Key Players and Competitive Insights
The China Refurbished Medical Devices Market is gaining considerable traction due to a growing demand for cost-effective healthcare solutions and an increasing emphasis on sustainable practices within the medical industry.
The competitive landscape is characterized by a blend of local and international players, each aiming to capitalize on the rising need for affordable medical equipment without compromising quality.
As healthcare costs continue to escalate in China, refurbished medical devices offer a viable alternative, attracting hospitals and clinics that seek to maintain high standards of care while managing budgets effectively.
The market dynamics reflect a robust competitive environment driven by innovative technologies, strategic partnerships, and regulatory compliance as firms navigate the complexities of a rapidly evolving healthcare system.
Johnson and Johnson holds a notable position in the China Refurbished Medical Devices Market, leveraging its strong brand equity and extensive portfolio of healthcare solutions. Known for its commitment to quality and innovation, Johnson and Johnson has refined its approach to refurbishment and resale of medical devices, ensuring compliance with local regulations and standards.
Its established reputation in the healthcare sector facilitates trust among healthcare providers, allowing it to maintain a significant market presence. Additionally, the company's strategic focus on providing tailored services to meet the unique needs of Chinese healthcare institutions positions it favorably against competitors.
The company's global network enhances its ability to source, refurbish, and distribute medical devices efficiently within the region, reinforcing its strength in the marketplace. Nihon Kohden is also a significant player in the China Refurbished Medical Devices Market, specializing in advanced medical electronics, particularly in the fields of patient monitoring and diagnostic equipment.
The company has developed a strong foothold in China through its state-of-the-art technology and a diverse range of key products such as ECG monitors, EEG machines, and infusion pumps. Nihon Kohden's commitment to quality and reliability helps it stand out among other competitors, particularly in the realm of refurbished devices.
Moreover, the company's strategies around mergers and acquisitions have bolstered its market presence, enabling it to integrate innovative solutions and expand its offerings in China.
With a robust service network and dedication to customer support, Nihon Kohden continues to enhance its competitive position in the refurbished medical devices space, catering to the evolving demands of healthcare providers across the country.
Key Companies in the China Refurbished Medical Devices Market Include
- Johnson and Johnson
- Nihon Kohden
- Philips Healthcare
- Carestream Health
- Toshiba Medical Systems
- Varian Medical Systems
- Stryker Corporation
- Siemens Healthineers
- Boston Scientific
- Hitachi Medical Systems
- Fujifilm Holdings
- B. Braun Melsungen
- Hologic
- Medtronic
- GE Healthcare
China Refurbished Medical Devices Market Developments
Recent developments in the China Refurbished Medical Devices Market reflect a dynamic landscape with significant growth prospects. Notably, companies like Johnson and Johnson and Philips Healthcare are actively enhancing their strategic initiatives to bolster their positions in the refurbishing segment, aligning with China's increasing demand for cost-effective healthcare solutions.
In May 2023, GE Healthcare announced an investment in refurbished imaging equipment, capitalizing on China's expanding healthcare infrastructure. Additionally, Nihon Kohden has been making strides in the rehabilitation sector by introducing advanced refurbished devices tailored for local markets.
Current affairs showcase a rising trend among healthcare institutions in China to transition to refurbished medical technologies, influenced by government policies aimed at reducing healthcare costs. Mergers and acquisitions have also shaped the market; Stryker Corporation recently acquired a local competitor in April 2023, focusing on strengthening its distribution network within China.
The overall market valuation has been positively impacted, with predictions indicating a robust CAGR of over 10% through 2027, driven by increasing health awareness and an aging population. Several companies, including Siemens Healthineers and Toshiba Medical Systems, are exploring partnerships to expand their refurbished offerings effectively in the region.
China Refurbished Medical Devices Market Segmentation Insights
Refurbished Medical Devices Market Diagnostic Devices Outlook
- X-Ray Machines
- CT Scanners
- Ultrasound Systems
- MRI Machines
- ECG Systems
- Patient Monitors
Refurbished Medical Devices Market Therapeutic Devices Outlook
- Heart-Lung Machines
- Coagulation Analyzers
- Infant Incubators and Warmers
- Defibrillators
- Infusion Pumps
Report Attribute/Metric Source: |
Details |
MARKET SIZE 2023 |
663.0(USD Million) |
MARKET SIZE 2024 |
739.8(USD Million) |
MARKET SIZE 2035 |
1882.4(USD Million) |
COMPOUND ANNUAL GROWTH RATE (CAGR) |
8.861% (2025 - 2035) |
REPORT COVERAGE |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR |
2024 |
MARKET FORECAST PERIOD |
2025 - 2035 |
HISTORICAL DATA |
2019 - 2024 |
MARKET FORECAST UNITS |
USD Million |
KEY COMPANIES PROFILED |
Johnson and Johnson, Nihon Kohden, Philips Healthcare, Carestream Health, Toshiba Medical Systems, Varian Medical Systems, Stryker Corporation, Siemens Healthineers, Boston Scientific, Hitachi Medical Systems, Fujifilm Holdings, B. Braun Melsungen, Hologic, Medtronic, GE Healthcare |
SEGMENTS COVERED |
Diagnostic Devices, Therapeutic Devices |
KEY MARKET OPPORTUNITIES |
Increasing demand for cost-effective care, Expanding healthcare infrastructure, Rising acceptance of pre-owned equipment, Government support for sustainability, Growth in telemedicine services |
KEY MARKET DYNAMICS |
Growing demand for cost-effective solutions, Government regulations and policies support, Technological advancements and innovations, Increasing awareness of sustainability, Rising healthcare expenditure and investments |
COUNTRIES COVERED |
China |
Frequently Asked Questions (FAQ) :
The China Refurbished Medical Devices Market is expected to be valued at 739.8 million USD in 2024.
By 2035, the market is anticipated to reach a valuation of 1882.4 million USD.
The market is projected to grow at a CAGR of 8.861% during the period from 2025 to 2035.
In 2024, the X-Ray Machines segment is expected to dominate, valued at 150.0 million USD.
The projected market value for X-Ray Machines in 2035 is 380.0 million USD.
Major players in the market include Johnson and Johnson, Philips Healthcare, and GE Healthcare among others.
The market value for MRI Machines in 2024 is anticipated to be 150.0 million USD.
By 2035, the ECG Systems segment is expected to reach a market value of 442.4 million USD.
In 2024, the market size for CT Scanners is expected to be valued at 145.0 million USD.
The market for Ultrasound Systems will grow from 120.0 million USD in 2024 to 300.0 million USD by 2035.